Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis (FINCH 4)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03025308

Recruitment Status : Active, not recruiting

First Posted : January 19, 2017

Last Update Posted : October 21, 2022

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborator:

Gilead Sciences

Information provided by (Responsible Party):

Galapagos NV

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	April 2025
Estimated Study Completion Date :	May 2025

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Combe B, Besuyen R, Gomez-Centeno A, Matsubara T, Sancho Jimenez JJ, Yin Z, Buch MH. Geographic Analysis of the Safety and Efficacy of Filgotinib in Rheumatoid Arthritis. Rheumatol Ther. 2023 Feb;10(1):35-51. doi: 10.1007/s40744-022-00494-1. Epub 2022 Oct 7.

To Top